Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cerebral thrombosis targeted prevention active drug composition and application thereof

A technology of drug activity and composition, applied in the field of cardiovascular and cerebrovascular drugs, can solve the problems of unsatisfactory treatment effect of cerebral thrombosis, weak treatment effect, etc., and achieves improvement of bioelectric signal conduction mechanism, enhancement of oxygen-carrying capacity, and reduction of lipid peroxides. qualitative effect

Inactive Publication Date: 2017-03-15
乌林奇
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The currently used drugs enter the blood circulation system through the peripheral veins, so the therapeutic effect on cerebral arterial embolism is already very weak, making the therapeutic effect of cerebral thrombosis unsatisfactory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Raw materials: 30g of anthocyanin extract, 300mL of mineral element solution, 3g of nicotinic acid, 2700mL of blueberry juice.

[0037] After mixing the above raw materials evenly, divide them into 50mL portions on average. Ordinary cerebral thrombosis patients take 50mL in the morning and evening, obese patients with cerebral thrombosis take 150mL a day, and take 50mL in the morning, noon and evening.

[0038] Man Dingming, male, 56 years old, a native of Xinjiang, currently lives in Luohu District, Shenzhen. Sudden cerebral thrombosis in 2015, manifested as basically no sensation in the right arm, only the tip of the thumb and index finger on the right hand felt slight touch, the arm could not be lifted by itself, and it was difficult to walk. After taking the pharmaceutically active composition of the present invention for 8 days, the hand has a slight sensation, and the five fingertips all feel touch, and the body is unobstructed and relaxed. After 10 days, the sen...

Embodiment 2

[0040] Raw materials: 20g of anthocyanin extract, 200mL of mineral element solution, 5g of nicotinic acid, 2800mL of hawthorn juice.

[0041] After mixing the above raw materials evenly, divide them into 50mL portions on average. Ordinary cerebral thrombosis patients take 50mL in the morning and evening, obese patients with cerebral thrombosis take 150mL a day, and take 50mL in the morning, noon and evening.

[0042] Wu Jingyu, female, 56 years old, is a native of Jiangxi Province and currently lives in Shenzhen. Suffering from cerebral thrombosis for nearly 10 years, varicose veins are very serious, accompanied by long-term insomnia, numb hands and feet, chest tightness, heart discomfort and other symptoms. After taking the pharmaceutically active composition of the present invention, the above symptoms are obviously relieved after 7 days, the patient's long-term sleep disorder is greatly improved, and the chest tightness is also greatly improved. After 20 days, all the abov...

Embodiment 3

[0044] Raw materials: 40g of anthocyanin extract, 400mL of mineral element solution, 1g of nicotinic acid, 2600mL of water.

[0045] After mixing the above raw materials evenly, divide them into 50mL portions on average. Patients with early and common cerebral thrombosis take 50mL in the morning and evening, and obese patients with cerebral thrombosis take 150mL a day, and take 50mL in the morning, noon and evening.

[0046] Ge Li, female, 47 years old, a native of Henan, currently lives in Shenzhen. Suffering from cerebral thrombosis, the symptoms include numbness in the forearm of both arms, dull touch, and facial stiffness. The tested blood sugar and uric acid values ​​have reached the borderline standard reference value. The initial detection, through the observation of cell images, shows that the blood viscosity and blood lipid are high, the blood stasis is serious, and the cell vitality is low. After taking the pharmaceutically active composition of the present inventio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Concentrationaaaaaaaaaa
Concentrationaaaaaaaaaa
Concentrationaaaaaaaaaa
Login to View More

Abstract

The invention provides a cerebral thrombosis targeted prevention active drug composition and application thereof. The cerebral thrombosis targeted prevention active drug composition is prepared by mixing the raw materials of anthocyanin-containing extracts, mineral element liquid and nicotinic acid. The cerebral thrombosis targeted prevention active drug composition can enhance the oxygen carrying capacity of red blood cells, activate fat, sugar and cholesterol metabolism enzymes, eliminate oxyradicals, change blood pH value, disperse seriously-adhered blood cells, and dilate blood vessels through the nicotinic acid to promote microcirculation and full metabolism of cells, water and electrolytes in blood. The cerebral thrombosis targeted prevention active drug composition is significant in effects on decomposing cerebral thrombosis blocks, eliminating heavy metal damage, penetrating blood brain barriers and fundamentally improving the bioelectric signal transduction mechanism of cerebral nervous tissues and achieves rapid and efficient prevention effects on hemidysesthesia, hemianopsia, aphasia, contralateral sensory disturbance, extraocular paralysis, eyeball motor paralysis, pupil anomalous, quadriplegia, conscious disturbance, uroclepsia and spastic paraplegia.

Description

technical field [0001] The present invention relates to the technical field of cardiovascular and cerebrovascular drugs, in particular to a drug active composition for targeted prevention and treatment of cerebral thrombosis and its application. Background technique [0002] The number of people who die from cerebral thrombosis is as high as 15 million every year in the world, and nearly 3 million people die from cerebral thrombosis every year in my country. Cerebral thrombosis disease has the characteristics of high prevalence rate, high disability rate and high mortality rate, ranking first among various causes of death. Cerebral thrombosis can directly cause symptoms such as hemiplegia, hemisensory disturbance, hemianopia, aphasia, or crossed paralysis, crossed sensory disturbance, external ophthalmoplegia, nystagmus, dysphagia, ataxia and vertigo. [0003] At present, the medical field generally adopts intravenous injection of blood vessel dilating and thrombus-dissolvi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K33/34A61P9/10A61P7/02A61K31/352A61K31/455A61K33/26A61K33/30A61K33/24A61K33/04
CPCA61K31/352A61K31/455A61K33/04A61K33/24A61K33/26A61K33/30A61K33/34A61K2300/00
Inventor 乌林奇
Owner 乌林奇
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com